Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

類似資料

• Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer
  著者:: Hunter, B A, 等
  出版事項: (2014)
• Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial()
  著者:: Eustace, Amanda, 等
  出版事項: (2013)
• A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer
  著者:: Eustace, Amanda, 等
  出版事項: (2013)
• A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer
  著者:: Khan, Mairah T., 等
  出版事項: (2021)
• Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis
  著者:: Blick, C, 等
  出版事項: (2015)